LC120 (Lipo-C Metabolic Blend)
LC120 (Lipo-C Metabolic Blend) is a weight management peptide used in evidence-based, physician-supervised protocols. Weekly lipotropic support to enhance fat mobilization, especially in liver-congested metabolic patients.
What is LC120 (Lipo-C Metabolic Blend)?
Lipotropic cocktail — Methionine (15mg) supports hepatic methyl donors; Choline (50mg) phospholipid synthesis and fat transport; L-Carnitine (50mg) mitochondrial fatty acid transport; B5 (5mg) CoA synthesis. Collectively promotes hepatic fat metabolism and fatty acid oxidation.
Uses & clinical decision logic
Weekly lipotropic support to enhance fat mobilization, especially in liver-congested metabolic patients. Adjunct to GLP-1 or exercise protocols.
LC120 (Lipo-C Metabolic Blend) dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 10mL | N/A (Ready-to-use) | 1mL | 1mL | 1-2x/week | IM/SubQ |
Safety & contraindications
IM injection preferred — SubQ may cause local irritation with some formulations.
Stacking & combinations
Pair with GLP-1 and GH peptides for comprehensive metabolic support.
Frequently asked questions
What is LC120 (Lipo-C Metabolic Blend) used for?
Weekly lipotropic support to enhance fat mobilization, especially in liver-congested metabolic patients. Adjunct to GLP-1 or exercise protocols.
What is the typical LC120 (Lipo-C Metabolic Blend) dosage?
Common dosing ranges from 1mL (1-2x/week, IM/SubQ). Exact dosing is individualized and set by a licensed physician.
How is LC120 (Lipo-C Metabolic Blend) administered?
LC120 (Lipo-C Metabolic Blend) is typically administered via IM/SubQ.
What are the contraindications for LC120 (Lipo-C Metabolic Blend)?
IM injection preferred — SubQ may cause local irritation with some formulations.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.